(Q48417173)

11 February 2018

title

Statins after transient ischaemic attack and ischaemic stroke. (English)

1 reference

11 February 2018

author

Graeme J. Hankey

series ordinal

1

1 reference

11 February 2018

publication date

1 October 2006

1 reference

11 February 2018

published in

Lancet Neurology

1 reference

11 February 2018

volume

5

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

810-812

1 reference

11 February 2018

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

What causes lacunar stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970559-2

7 January 2021

10.1016/S1474-4422(06)70559-2

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018